nature.com search

Loading Filters

Showing 1–19 of 19 results

Loading Filters

Amendments and Corrections | 7 September 2016
Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells
- R Thijssen
- , J ter Burg
- , G G W van Bochove
- , M F M de Rooij
- , A Kuil
- , M H Jansen
- , T W Kuijpers
- , J W Baars
- , A Virone-Oddos
- , M Spaargaren
- , C Egile
- , M H J van Oers
- , E Eldering
- , M J Kersten
- & A P Kater
Leukemia 30 , 1963–1963

Rights & permissionsfor article Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells . Opens in a new window.
23 June 2016 | Open
The APRIL paradox in normal versus malignant B cell biology
Cell Death & Disease 7 , e2276–e2276

Rights & permissionsfor article The APRIL paradox in normal versus malignant B cell biology . Opens in a new window.
2 April 2009
Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction
- R Mous
- , A Jaspers
- , D M P Luijks
- , C H M Mellink
- , M H J van Oers
- , A P Kater
- & E Eldering
Leukemia 23 , 1352–1355

Rights & permissionsfor article Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction . Opens in a new window.
3 December 2009
R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia
- S H Tonino
- , M van Gelder
- , E Eldering
- , M H van Oers
- & A P Kater
Leukemia 24 , 652–654

Rights & permissionsfor article R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia . Opens in a new window.
Research | 2 May 2017
Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition
- E Slinger
- , R Thijssen
- , A P Kater
- & E Eldering
Leukemia 31 , 2601–2607

Rights & permissionsfor article Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition . Opens in a new window.
Research | 15 February 2016
Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study
- M van Gelder
- , M H van Oers
- , W G Alemayehu
- , M C J Abrahamse-Testroote
- , J J Cornelissen
- , M E Chamuleau
- , P Zachée
- , M Hoogendoorn
- , M Nijland
- , E J Petersen
- , A Beeker
- , G-J Timmers
- , L Verdonck
- , M Westerman
- , O de Weerdt
- & A P Kater
Bone Marrow Transplantation 51 , 799–806

Rights & permissionsfor article Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study . Opens in a new window.
2 February 2012
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia
- S Pospisilova
- , D Gonzalez
- , J Malcikova
- , M Trbusek
- , D Rossi
- , A P Kater
- , F Cymbalista
- , B Eichhorst
- , M Hallek
- , H Döhner
- , P Hillmen
- , M van Oers
- , J Gribben
- , P Ghia
- , E Montserrat
- , S Stilgenbauer
- & T Zenz
Leukemia 26 , 1458–1461

Rights & permissionsfor article ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia . Opens in a new window.
Reviews | 2 February 2018 | Open
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation
- J. Malcikova
- , E. Tausch
- , D. Rossi
- , L. A. Sutton
- , T. Soussi
- , T. Zenz
- , A. P. Kater
- , C. U. Niemann
- , D. Gonzalez
- , F. Davi
- , M. Gonzalez Diaz
- , C. Moreno
- , G. Gaidano
- , K. Stamatopoulos
- , R. Rosenquist
- , S. Stilgenbauer
- , P. Ghia
- & S. Pospisilova
Leukemia 32 , 1070–1080

Rights & permissionsfor article ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation . Opens in a new window.
Research | 13 February 2017 | Open
Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia
- M H A van Attekum
- , S Terpstra
- , E Slinger
- , M von Lindern
- , P D Moerland
- , A Jongejan
- , A P Kater
- & E Eldering
Oncogene 36 , 3651–3660

Rights & permissionsfor article Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia . Opens in a new window.
Research | 6 August 2015 | Open
Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification
- G D te Raa
- , P D Moerland
- , A C Leeksma
- , I A Derks
- , H Yigittop
- , N Laddach
- , M Loden-van Straaten
- , V Navrkalova
- , M Trbusek
- , D M Luijks
- , T Zenz
- , A Skowronska
- , M Hoogendoorn
- , T Stankovic
- , M H van Oers
- , E Eldering
- & A P Kater
Cell Death & Disease 6 , e1852–e1852

Rights & permissionsfor article Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification . Opens in a new window.
Research | 7 December 2015 | Open
A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study
- A C Rawstron
- , C Fazi
- , A Agathangelidis
- , N Villamor
- , R Letestu
- , J Nomdedeu
- , C Palacio
- , O Stehlikova
- , K-A Kreuzer
- , S Liptrot
- , D O'Brien
- , R M de Tute
- , I Marinov
- , M Hauwel
- , M Spacek
- , J Dobber
- , A P Kater
- , P Gambell
- , A Soosapilla
- , G Lozanski
- , G Brachtl
- , K Lin
- , J Boysen
- , C Hanson
- , J L Jorgensen
- , M Stetler-Stevenson
- , C Yuan
- , H E Broome
- , L Rassenti
- , F Craig
- , J Delgado
- , C Moreno
- , F Bosch
- , A Egle
- , M Doubek
- , S Pospisilova
- , S Mulligan
- , D Westerman
- , C M Sanders
- , R Emerson
- , H S Robins
- , I Kirsch
- , T Shanafelt
- , A Pettitt
- , T J Kipps
- , W G Wierda
- , F Cymbalista
- , M Hallek
- , P Hillmen
- , E Montserrat
- & P Ghia
Leukemia 30 , 929–936

Rights & permissionsfor article A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study . Opens in a new window.
Research | 14 May 2015
p53-dependent non-coding RNA networks in chronic lymphocytic leukemia
- C J Blume
- , A Hotz-Wagenblatt
- , J Hüllein
- , L Sellner
- , A Jethwa
- , T Stolz
- , M Slabicki
- , K Lee
- , A Sharathchandra
- , A Benner
- , S Dietrich
- , C C Oakes
- , P Dreger
- , D te Raa
- , A P Kater
- , A Jauch
- , O Merkel
- , M Oren
- , T Hielscher
- & T Zenz
Leukemia 29 , 2015–2023

Rights & permissionsfor article p53-dependent non-coding RNA networks in chronic lymphocytic leukemia . Opens in a new window.
Research | 5 November 2014
The impact of SF3B1 mutations in CLL on the DNA-damage response
- G D te Raa
- , I A M Derks
- , V Navrkalova
- , A Skowronska
- , P D Moerland
- , J van Laar
- , C Oldreive
- , H Monsuur
- , M Trbusek
- , J Malcikova
- , M Lodén
- , C H Geisler
- , J Hüllein
- , A Jethwa
- , T Zenz
- , S Pospisilova
- , T Stankovic
- , M H J van Oers
- , A P Kater
- & E Eldering
Leukemia 29 , 1133–1142

Rights & permissionsfor article The impact of SF3B1 mutations in CLL on the DNA-damage response . Opens in a new window.
Research | 4 September 2015
The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells
- R Thijssen
- , J ter Burg
- , G G W van Bochove
- , M F M de Rooij
- , A Kuil
- , M H Jansen
- , T W Kuijpers
- , J W Baars
- , A Virone-Oddos
- , M Spaargaren
- , C Egile
- , M H J van Oers
- , E Eldering
- , M J Kersten
- & A P Kater
Leukemia 30 , 337–345

Rights & permissionsfor article The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells . Opens in a new window.
23 June 2014
BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future
- M Spaargaren
- , M F M de Rooij
- , A P Kater
- & E Eldering
Oncogene 34 , 2426–2436

Rights & permissionsfor article BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future . Opens in a new window.
Research | 1 October 2012 | Open
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
- R Oostvogels
- , M C Minnema
- , M van Elk
- , R M Spaapen
- , G D te Raa
- , B Giovannone
- , A Buijs
- , D van Baarle
- , A P Kater
- , M Griffioen
- , E Spierings
- , H M Lokhorst
- & T Mutis
Leukemia 27 , 642–649

Rights & permissionsfor article Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1 . Opens in a new window.
Research | 28 June 2010
Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering
- J M Tromp
- , S H Tonino
- , J A Elias
- , A Jaspers
- , D M Luijks
- , A P Kater
- , R A W van Lier
- , M H J van Oers
- & E Eldering
Oncogene 29 , 5071–5082

Rights & permissionsfor article Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering . Opens in a new window.
Research | 11 October 2010
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia
- S H Tonino
- , J van Laar
- , M H van Oers
- , J Y Wang
- , E Eldering
- & A P Kater
Oncogene 30 , 701–713

Rights & permissionsfor article ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia . Opens in a new window.
20 January 2005
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation
- W J M Mackus
- , A P Kater
- , A Grummels
- , L M Evers
- , B Hooijbrink
- , M H H Kramer
- , J E Castro
- , T J Kipps
- , R A W van Lier
- , M H J van Oers
- & E Eldering
Leukemia 19 , 427–434

Rights & permissionsfor article Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation . Opens in a new window.

Refine your results by…

Filters

Filter By:

Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

The APRIL paradox in normal versus malignant B cell biology

Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction

R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia

Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition

Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

p53-dependent non-coding RNA networks in chronic lymphocytic leukemia

The impact of SF3B1 mutations in CLL on the DNA-damage response

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future

Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1

Dichotomy in NF-κB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering

ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia

Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters